Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Journal of Clinical Pharmacology|April 1, 1992
The pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients with various degrees of renal functionC E Halstenson, J A Opsahl, K Rachael, et al.Journal of Clinical Pharmacology|February 1, 1989
Disposition of guanadrel in subjects with normal and impaired renal functionC E Halstenson, J A Opsahl, P A Abraham, et al.Journal of Clinical Pharmacology|April 1, 1995
Pharmacokinetics of bepridil and two of its metabolites in patients with end-stage renal diseaseW M Awni, C E Halstenson, R K Nayak, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1991
Disposition of the cephalosporin cefepime in normal and renally impaired subjectsR H Barbhaiya, C A Knupp, S T Forgue, et al.Clinical Pharmacology and Therapeutics|January 1, 1988
Pharmacokinetics and pharmacodynamics of codeine in end-stage renal diseaseD R Guay, W M Awni, J W Findlay, et al.Journal of Clinical Pharmacology|December 1, 1987
Pharmacokinetics of codeine after single- and multiple-oral-dose administration to normal volunteersD R Guay, W M Awni, C E Halstenson, et al.Clinical Pharmacology and Therapeutics|October 1, 1986
The disposition and dynamics of labetalol in patients on dialysisC E Halstenson, J A Opsahl, T V Pence, et al.Antimicrobial Agents and Chemotherapy|April 1, 1990
Disposition of cefmetazole in healthy volunteers and patients with impaired renal functionC E Halstenson, D R Guay, J A Opsahl, et al.Clinical Pharmacology and Therapeutics|August 1, 1992
Epoetin enhances erythropoiesis in normal men undergoing repeated phlebotomiesP A Abraham, C E Halstenson, M M Macres, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1990
Body fluid spaces and blood pressure in hemodialysis patients during amelioration of anemia with erythropoietinP A Abraham, J A Opsahl, P R Keshaviah, et al.Pageof 6